222 related articles for article (PubMed ID: 8326001)
21. Mapping of a Coccidioides immitis-specific epitope that reacts with complement-fixing antibody.
Yang MC; Magee DM; Cox RA
Infect Immun; 1997 Oct; 65(10):4068-74. PubMed ID: 9317009
[TBL] [Abstract][Full Text] [Related]
22. The WI-1 adhesin blocks phagocyte TNF-alpha production, imparting pathogenicity on Blastomyces dermatitidis.
Finkel-Jimenez B; Wüthrich M; Brandhorst T; Klein BS
J Immunol; 2001 Feb; 166(4):2665-73. PubMed ID: 11160330
[TBL] [Abstract][Full Text] [Related]
23. Preparation and ELISA evaluation of Blastomyces dermatitidis yeast phase lysate antigens.
Johnson SM; Scalarone GM
Diagn Microbiol Infect Dis; 1988 Oct; 11(2):81-6. PubMed ID: 3229098
[TBL] [Abstract][Full Text] [Related]
24. Detection of antibody responses and delayed dermal hypersensitivity with Blastomyces dermatitidis yeast and mycelial lysate antigens.
Seawell BW; Wheeler JY; Yearsley K; Alexander KL; Legendre AM; Scalarone GM
Mycopathologia; 1991 Jun; 114(3):137-44. PubMed ID: 1886639
[TBL] [Abstract][Full Text] [Related]
25. Altered expression of surface protein WI-1 in genetically related strains of Blastomyces dermatitidis that differ in virulence regulates recognition of yeasts by human macrophages.
Klein BS; Chaturvedi S; Hogan LH; Jones JM; Newman SL
Infect Immun; 1994 Aug; 62(8):3536-42. PubMed ID: 8039924
[TBL] [Abstract][Full Text] [Related]
26. Serological differences in three Blastomyces dermatitidis strains.
Axtell RC; Scalarone GM
Mycoses; 2002 Dec; 45(11-12):437-42. PubMed ID: 12472717
[TBL] [Abstract][Full Text] [Related]
27. Comparative serological evaluation of 10 Blastomyces dermatitidis yeast phase lysate antigens from different sources.
Abuodeh RO; Chester EM; Scalarone GM
Mycoses; 2004 Apr; 47(3-4):143-9. PubMed ID: 15078431
[TBL] [Abstract][Full Text] [Related]
28. Structure and function of a fungal adhesin that binds heparin and mimics thrombospondin-1 by blocking T cell activation and effector function.
Brandhorst TT; Roy R; Wüthrich M; Nanjappa S; Filutowicz H; Galles K; Tonelli M; McCaslin DR; Satyshur K; Klein B
PLoS Pathog; 2013; 9(7):e1003464. PubMed ID: 23853587
[TBL] [Abstract][Full Text] [Related]
29. Recombinant Coccidioides immitis complement-fixing antigen: detection of an epitope shared by C. immitis, Histoplasma capsulatum, and Blastomyces dermatitidis.
Yang MC; Magee DM; Kaufman L; Zhu Y; Cox RA
Clin Diagn Lab Immunol; 1997 Jan; 4(1):19-22. PubMed ID: 9008276
[TBL] [Abstract][Full Text] [Related]
30. Blastomyces Antigen Detection for Diagnosis and Management of Blastomycosis.
Frost HM; Novicki TJ
J Clin Microbiol; 2015 Nov; 53(11):3660-2. PubMed ID: 26338856
[TBL] [Abstract][Full Text] [Related]
31. Utility of anti-WI-1 serological testing in the diagnosis of blastomycosis in Wisconsin residents.
Soufleris AJ; Klein BS; Courtney BT; Proctor ME; Jones JM
Clin Infect Dis; 1994 Jul; 19(1):87-92. PubMed ID: 7948563
[TBL] [Abstract][Full Text] [Related]
32. Blastomyces dermatitidis antigen-induced lymphocytes reactivity in human blastomycosis.
Bradsher RW; Alford RH
Infect Immun; 1981 Aug; 33(2):485-90. PubMed ID: 7024130
[TBL] [Abstract][Full Text] [Related]
33. Immunohistopathological studies of blastomycosis: the use of labeled specific antigens in a hamster model of disease.
Korkij W; Soltani K; Chyu JY; Rippon JW
Mycopathologia; 1984 Mar; 85(1-2):17-20. PubMed ID: 6427614
[TBL] [Abstract][Full Text] [Related]
34. Sensitivity and specificity of an isoelectric focusing fraction of Blastomyces dermatitidis yeast lysate antigen for the detection of canine blastomycosis.
Fisher MA; Bono JL; Abuodeh RO; Legendre AM; Scalarone GM
Mycoses; 1995; 38(5-6):177-82. PubMed ID: 8531928
[TBL] [Abstract][Full Text] [Related]
35. Enzyme immunoassay detection of antibodies in canine blastomycosis using Blastomyces dermatitidis lysate antigens.
Seawell BW; Legendre AM; Scalarone GM
Mycoses; 1990; 33(9-10):483-9. PubMed ID: 2093845
[TBL] [Abstract][Full Text] [Related]
36. Development of a highly sensitive and specific blastomycosis antibody enzyme immunoassay using Blastomyces dermatitidis surface protein BAD-1.
Richer SM; Smedema ML; Durkin MM; Brandhorst TT; Hage CA; Connolly PA; Leland DS; Davis TE; Klein BS; Wheat LJ
Clin Vaccine Immunol; 2014 Feb; 21(2):143-6. PubMed ID: 24285817
[TBL] [Abstract][Full Text] [Related]
37. Development of a slide agglutination assay for detection of blastomycosis.
Hatch WO; Scalarone GM
Microbiol Immunol; 2013 Nov; 57(11):756-61. PubMed ID: 24028710
[TBL] [Abstract][Full Text] [Related]
38. Detection of antibodies and delayed hypersensitivity with Rotofor preparative IEF fractions of Blastomyces dermatitidis yeast phase lysate antigen.
Bono JL; Legendre AM; Scalarone GM
J Med Vet Mycol; 1995; 33(4):209-14. PubMed ID: 8531017
[TBL] [Abstract][Full Text] [Related]
39. Cell wall biogenesis of Blastomyces dermatitidis. Evidence for a novel mechanism of cell surface localization of a virulence-associated adhesin via extracellular release and reassociation with cell wall chitin.
Brandhorst T; Klein B
J Biol Chem; 2000 Mar; 275(11):7925-34. PubMed ID: 10713109
[TBL] [Abstract][Full Text] [Related]
40. Role of glucan and surface protein BAD1 in complement activation by Blastomyces dermatitidis yeast.
Zhang MX; Brandhorst TT; Kozel TR; Klein BS
Infect Immun; 2001 Dec; 69(12):7559-64. PubMed ID: 11705933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
